Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference
September 11, 2024 16:05 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference
Eledon Announces Completion of Enrollment in Phase 2 BESTOW Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients
September 04, 2024 07:00 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Announces Completion of Enrollment in Phase 2 BESTOW Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplants
American Institutes for Research to Support Efforts to Strengthen U.S. System for Organ Donation and Transplantation
September 03, 2024 12:30 ET
|
American Institutes for Research
Arlington, Va., Sept. 03, 2024 (GLOBE NEWSWIRE) -- The Health Resources and Services Administration (HRSA) has awarded the American Institutes for Research (AIR) a five-year contract to strengthen...
Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results
August 14, 2024 17:21 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results
Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection
July 29, 2024 07:00 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection
Translational Regenerative Medicine Market Set to Surpass $77 Billion in 2024
June 06, 2024 04:10 ET
|
Research and Markets
Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "Translational Regenerative Medicine Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.Overall world revenue for the...
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
May 09, 2024 07:30 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress
May 09, 2024 07:00 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at ATC 2024
Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
May 07, 2024 07:05 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
May 07, 2024 07:00 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement